IA
EW icon

Integrity Alliance’s Edwards Lifesciences EW Stock Holding History

Integrity Alliance’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$225K Buy
2,804
+41
+1% +$3.38K 0.01% 674
2025
Q4 		$236K Buy
+2,763
New +$227K 0.01% 680
2025
Q2 		– Sell
-3,168
Closed -$230K – 533
2025
Q1 		$230K Buy
+3,168
New +$227K 0.01% 553

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Integrity Alliance's EW Position: Q1 2026 in Review

Integrity Alliance increased its Edwards Lifesciences (EW) stake by 1.5% in Q1 2026, buying an estimated $3.38K and bringing the position to 2,804 shares worth $225K. The position accounts for 0.01% of the portfolio, ranked #674.

Integrity Alliance first reported a position in EW in Q1 2025 and has held it in 3 quarters since. The position peaked at $236K in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Integrity Alliance held 2,804 shares of Edwards Lifesciences worth $225K as of Q1 2026.
  • Integrity Alliance bought 41 Edwards Lifesciences shares in Q1 2026, an estimated $3.38K.
  • Edwards Lifesciences made up 0.01% of Integrity Alliance's portfolio in Q1 2026, its #674 holding.
  • Integrity Alliance first reported a position in Edwards Lifesciences in Q1 2025 and has held it in 3 quarters since.
  • Integrity Alliance's Edwards Lifesciences position peaked at $236K in Q4 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Integrity Alliance's 13F filing for Q1 2026, filed 11 May 2026.